Joseph Taylor, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcranial Magnetic Stimulation | 12 | 2023 | 1496 | 2.090 |
Why?
|
| Prefrontal Cortex | 7 | 2023 | 2223 | 0.820 |
Why?
|
| Psychiatry | 5 | 2022 | 1715 | 0.640 |
Why?
|
| Analgesia | 2 | 2013 | 461 | 0.580 |
Why?
|
| Mental Disorders | 5 | 2023 | 6872 | 0.530 |
Why?
|
| Hallucinations | 1 | 2017 | 373 | 0.470 |
Why?
|
| Helplessness, Learned | 1 | 2014 | 25 | 0.470 |
Why?
|
| Opioid Peptides | 1 | 2012 | 37 | 0.390 |
Why?
|
| Naloxone | 1 | 2013 | 373 | 0.340 |
Why?
|
| Brain Mapping | 4 | 2021 | 6598 | 0.320 |
Why?
|
| Deep Brain Stimulation | 1 | 2017 | 848 | 0.310 |
Why?
|
| Seizures | 2 | 2021 | 2997 | 0.310 |
Why?
|
| Pain | 2 | 2013 | 5076 | 0.280 |
Why?
|
| Neural Pathways | 2 | 2017 | 3087 | 0.280 |
Why?
|
| Neurology | 1 | 2015 | 784 | 0.280 |
Why?
|
| Brain Diseases | 1 | 2015 | 1551 | 0.260 |
Why?
|
| Electroconvulsive Therapy | 3 | 2018 | 505 | 0.250 |
Why?
|
| Education, Medical | 1 | 2015 | 1746 | 0.210 |
Why?
|
| Brain | 7 | 2023 | 27178 | 0.200 |
Why?
|
| Clinical Competence | 1 | 2015 | 4860 | 0.160 |
Why?
|
| Atrophy | 1 | 2023 | 1629 | 0.140 |
Why?
|
| Physicians | 1 | 2015 | 4587 | 0.140 |
Why?
|
| Gyrus Cinguli | 1 | 2023 | 1116 | 0.130 |
Why?
|
| Cross-Over Studies | 2 | 2013 | 2108 | 0.130 |
Why?
|
| Art | 1 | 2015 | 66 | 0.120 |
Why?
|
| Chorioamnionitis | 1 | 2015 | 154 | 0.120 |
Why?
|
| Brain Stem Neoplasms | 1 | 2016 | 192 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 2015 | 262 | 0.110 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2013 | 80 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2018 | 1573 | 0.100 |
Why?
|
| Astrocytoma | 1 | 2016 | 772 | 0.100 |
Why?
|
| Methamphetamine | 1 | 2013 | 166 | 0.090 |
Why?
|
| Limbic System | 1 | 2013 | 418 | 0.090 |
Why?
|
| Depressive Disorder | 2 | 2014 | 3711 | 0.090 |
Why?
|
| Decompressive Craniectomy | 1 | 2011 | 76 | 0.090 |
Why?
|
| Humans | 22 | 2023 | 765823 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2018 | 2761 | 0.090 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 663 | 0.080 |
Why?
|
| Triazines | 1 | 2011 | 306 | 0.080 |
Why?
|
| Specialization | 1 | 2014 | 779 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2015 | 958 | 0.080 |
Why?
|
| Valproic Acid | 1 | 2011 | 444 | 0.080 |
Why?
|
| Pedunculopontine Tegmental Nucleus | 1 | 2008 | 17 | 0.080 |
Why?
|
| Electric Stimulation Therapy | 1 | 2014 | 634 | 0.080 |
Why?
|
| Cues | 1 | 2013 | 877 | 0.080 |
Why?
|
| Comorbidity | 1 | 2023 | 10570 | 0.070 |
Why?
|
| Narcotic Antagonists | 1 | 2013 | 590 | 0.070 |
Why?
|
| Central Nervous System Stimulants | 1 | 2013 | 1167 | 0.060 |
Why?
|
| Double-Blind Method | 3 | 2015 | 12421 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2014 | 8725 | 0.050 |
Why?
|
| Adult | 6 | 2023 | 223055 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2013 | 3559 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2011 | 1919 | 0.050 |
Why?
|
| Acute Disease | 1 | 2012 | 7237 | 0.050 |
Why?
|
| Psychotic Disorders | 1 | 2016 | 3272 | 0.050 |
Why?
|
| Action Potentials | 1 | 2008 | 1837 | 0.040 |
Why?
|
| Motor Cortex | 1 | 2008 | 1003 | 0.040 |
Why?
|
| Curriculum | 1 | 2014 | 3780 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2011 | 2061 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 54798 | 0.040 |
Why?
|
| Young Adult | 3 | 2014 | 59849 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2014 | 4627 | 0.030 |
Why?
|
| Functional Laterality | 2 | 2013 | 2243 | 0.030 |
Why?
|
| Male | 8 | 2016 | 363740 | 0.030 |
Why?
|
| Child | 1 | 2023 | 80509 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 5764 | 0.030 |
Why?
|
| Echoencephalography | 1 | 2015 | 134 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2008 | 2891 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2014 | 5944 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 463 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2023 | 65223 | 0.030 |
Why?
|
| Depression | 1 | 2013 | 8224 | 0.030 |
Why?
|
| Female | 5 | 2015 | 396050 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2015 | 36542 | 0.020 |
Why?
|
| Adolescent | 3 | 2016 | 88794 | 0.020 |
Why?
|
| Vagus Nerve | 1 | 2013 | 458 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1587 | 0.020 |
Why?
|
| Neurons | 1 | 2008 | 9521 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18289 | 0.020 |
Why?
|
| Fetus | 1 | 2015 | 1878 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 2013 | 1218 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2013 | 1993 | 0.020 |
Why?
|
| Thalamus | 1 | 2013 | 1048 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2013 | 1987 | 0.020 |
Why?
|
| Movement | 1 | 2013 | 1460 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 2674 | 0.020 |
Why?
|
| Mothers | 1 | 2015 | 2207 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2011 | 1748 | 0.010 |
Why?
|
| Dopamine | 1 | 2008 | 1583 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 3686 | 0.010 |
Why?
|
| Hippocampus | 1 | 2013 | 3774 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2015 | 6274 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 223016 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 8105 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 8927 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 10383 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2015 | 26337 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 20131 | 0.010 |
Why?
|
| Pregnancy | 1 | 2015 | 30215 | 0.010 |
Why?
|
| Infant | 1 | 2015 | 36375 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 23707 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 26276 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 168730 | 0.000 |
Why?
|